ロード中...
Oral Delivery of Metformin by Chitosan Nanoparticles for Polycystic Kidney Disease
Nanoparticle drug delivery has many advantages over small molecule therapeutics, including reducing off-target side effects and increasing drug potency. However, many nanoparticles are administered parenterally, which is challenging for chronic diseases such as polycystic kidney disease (PKD), the m...
保存先:
| 出版年: | J Control Release |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904655/ https://ncbi.nlm.nih.gov/pubmed/33127449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.10.047 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|